Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-057821
Filing Date
2025-06-09
Accepted
2025-06-09 16:06:53
Documents
1
Period of Report
2025-06-05

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2517366-7_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2517366-7_4seq1.xml 4 5972
  Complete submission text file 0001104659-25-057821.txt   7426
Mailing Address MERRIMACK PHARMACEUTICALS, INC. ONE KENDALL SQUARE, SUITE B7201 CAMBRIDGE MA 02139
Business Address
Peters Richard (Reporting) CIK: 0001697628 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39069 | Film No.: 251034089

Mailing Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 215-948-4119
Aprea Therapeutics, Inc. (Issuer) CIK: 0001781983 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)